PR Newswire UK Disclose - LILLY (ELI) & COMPANY - LLY - Data Suggests Cymbalta(R) GAD APA.
Related Results
Lilly prepares for Cymbalta launch
Duloxetine lifts arthritis pain, aids cognition.(Psychosomatic Medicine)
Data Suggest Cymbalta(R) Improved Functioning in Patients With Generalized An…
FDA Approves Cymbalta(R) for Treatment of Generalized Anxiety Disorder
Duloxetine improves depression, pain, cognition.
re>
Date: May 21, 2007
For Release: 2 p.m. EST/11 a.m. PST , May 21, 2007
Refer to: Tamara Hull (US) 317-651-9116; mobile: 317-614-5132
David Shaffer (OUS) 317-651-3710; mobile: 317-614-5106
Data Suggest CymbaltaA[R] Improved Functioning in Patients with Generalized
Anxiety Disorder
Relationship Between Ability to Function and Treatment
of Anxious and Painful Physical Symptoms Studied
INDIANAPOLIS - Data suggest that patients with generalized anxiety disorder
(GAD) treated with CymbaltaA[R] (duloxetine HCl) …
Read the rest of this article with a Free Trial at HighBeam Research.
